Friday 6 November 2026 Export ABT’s income statement to Excel — free account

Abbott Laboratories

ABT Healthcare Medical Devices

Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024.

Revenue: +14.5%
EPS: −43.6%
Free cash flow: +28.9%
Total debt: +142.7%

Quarter to September 2026, against a year earlier

110.37 3.23 −2.84%

Follow ABT

Alert me

Market cap: $196.6B
P/E: 42.3×
Fwd P/E: 35.1×
Dividend yield: 2.22%
F-score: 5/9
Altman Z: 5.61
Beneish M: −2.50
Dividend safety: 62/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Abbott Laboratories (ABT) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Abbott Laboratories (ABT) trades at a P/S ratio of 4.1×. Over the past ten years it has ranged from 2.7× (February 2016) to 6.6× (February 2021); the current reading is higher than 42% of that period. That is above the Medical Devices industry median of 2.5× and above the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ABT/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Abbott Laboratories P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ABT/metrics/ps-ratio">Abbott Laboratories (ABT) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	4.9×	4.89%
FY2024	4.7×	(1.55%)
FY2023	4.8×	8.29%
FY2022	4.4×	(24.12%)
FY2021	5.8×	3.39%
FY2020	5.6×	16.53%
FY2019	4.8×	15.75%
FY2018	4.2×	11.34%
FY2017	3.7×	35.03%
FY2016	2.8×	(16.00%)

Period	P/S ratio	Change
Sep 2026	3.6×	5.20%
Jun 2026	3.4×	(14.47%)
Mar 2026	4.0×	(19.45%)
Dec 2025	4.9×	(7.54%)
43 more quarters	Free account

Against its own ten years

Low 2.7× High 6.6×

Ten-year median 4.4×

Current reading's percentile 36

Company	P/S ratio
PHG Koninklijke Philips N.V. compare	1.4×
GEHC GE HealthCare Technologies Inc. compare	1.7×
BSX Boston Scientific Corporation compare	3.1×
MDT Medtronic PLC compare	3.6×
STE STERIS plc compare	4.0×
ABT Abbott Laboratories	4.1×
SYK Stryker Corporation compare	4.9×
DXCM DexCom, Inc. compare	6.2×
EW Edwards Lifesciences Corporation compare	8.7×
Medical Devices industry median	2.5×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

Abbott Laboratories (ABT) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on ABT

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on ABT

Stockrow Weekly